We have just got back from this year’s Society of Toxicology meeting. It was an enjoyable and productive meeting, and great to see everyone there.

Thanks to everyone who attended Instem’s exhibitor hosted sessions on “Implementation of a Weight of Evidence Carcinogenicity Assessment Aligned with ICH S1B” and “Assessing N-nitrosamine Potency Classes”. There were a lot of interest and questions around the preparation of regulatory submissions to address these important topics. Unfortunately, the room was not large enough to accommodate all who wanted to attend; however, we will have the recording of the session available in the near future.

Thanks also to all who stopped-by the nine posters that Instem was a co-author on.1

Please get in touch if you would like us to send the recording of the sessions or to discuss the above in more detail (Glenn Myatt; glenn.myatt@instem.com).

Reference

  1. In Silico Insider – Nine Instem Posters at the 2023 SOT Meeting

Published by Glenn Myatt

Glenn J. Myatt is the co-founder of Leadscope and currently Senior Vice President, In Silico & Translational Science Solutions at Instem with over 30 years’ experience in computational chemistry/toxicology. He holds a Bachelor of Science degree in Computing, a Master of Science degree in Artificial Intelligence and a Ph.D. in Chemoinformatics. He has published 37 papers, 11 book chapters and three books.